Cargando…
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues
PURPOSE OF REVIEW: The omega-3 fatty acids (n3-FAs), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have recently undergone testing for their ability to reduce residual cardiovascular (CV) risk among statin-treated subjects. The outcome trials have yielded highly inconsistent results, p...
Autores principales: | Sherratt, Samuel C. R., Libby, Peter, Budoff, Matthew J., Bhatt, Deepak L., Mason, R. Preston |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834373/ https://www.ncbi.nlm.nih.gov/pubmed/36580204 http://dx.doi.org/10.1007/s11883-022-01075-x |
Ejemplares similares
-
Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid
por: Mason, R. Preston, et al.
Publicado: (2020) -
Comparative Effects of Mineral Oil, Corn Oil, Eicosapentaenoic Acid, and Docosahexaenoic Acid in an In Vitro Atherosclerosis Model
por: Sherratt, Samuel C. R., et al.
Publicado: (2023) -
Mechanistic insights into cardiovascular protection for omega-3 fatty acids and their bioactive lipid metabolites
por: O’Connell, Timothy D, et al.
Publicado: (2020) -
Is there a role for omega-3 fatty acids in cardiovascular disease risk reduction?
por: Mason, R.Preston, et al.
Publicado: (2021) -
New Insights into Mechanisms of Action for Omega-3 Fatty Acids in Atherothrombotic Cardiovascular Disease
por: Preston Mason, R.
Publicado: (2019)